ARTICLE | Company News
LSBC, ApoImmune protein production deal
March 22, 2002 8:00 AM UTC
Large Scale Biology (LSBC) will produce two of ApoImmune's polypeptides for use as cancer vaccine adjuvants. The deal combines LSBC's GeneWare manufacturing technology with ProtEx cancer cell targetin...